Matthew Call I Teos Therapeutics, Inc. (ITOS) insider trading activity

ITOS Quotes by TradingView

Matthew Call is Chief Operating Officer of iTeos Therapeutics, Inc.. Currently has a direct ownership of 161,898 shares of ITOS, which is worth approximately $1.13 Million. The most recent transaction as insider was on Mar 07, 2025, when has been sold 24,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K
17.4% 3M change
17.4% 12M change
Total Value Held $1.13 Million

Matthew Call Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2025
BUY
Grant, award, or other acquisition
-
24,000 Added 12.91%
161,898 Common Stock
Dec 05 2023
BUY
Grant, award, or other acquisition
-
44,000 Added 24.19%
137,898 Common Stock
Mar 28 2023
BUY
Exercise of conversion of derivative security
$118,666 $2.95 p/Share
40,226 Added 29.99%
93,898 Common Stock
Jul 30 2021
BUY
Exercise of conversion of derivative security
$158,332 $2.95 p/Share
53,672 Added 50.0%
53,672 Common Stock
MC

Matthew Call

Chief Operating Officer
Watertown, MA

Track Institutional and Insider Activities on ITOS

Follow iTeos Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITOS shares.

Notify only if

Insider Trading

Get notified when an I Teos Therapeutics, Inc. insider buys or sells ITOS shares.

Notify only if

News

Receive news related to iTeos Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ITOS